AdvanDx

AdvanDx

Rapid diagnostics for critical infections. Improving antibiotic decisions and patient outcomes..
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$3.5m

Debt
N/A

$2.2m

Early VC

$12.0m

Early VC
N/A

$2.5m

Debt

N/A

Acquisition
Total Funding€47.5m

Recent News about AdvanDx

Edit